CRISPR/Cas12a-assisted nucleic acid assays have shown great potential for rapid pathogen detection. However, their implementation in lateral flow assays remains constrained by strict protospacer adjacent motif (PAM) requirements and low-contrast, signal-off readouts. To effectively address these limitations, we present a new PAM-free programmable enzymatic cascade-enabled CRISPR/Cas12a lateral flow assay (PAEC-LFA) for highly sensitive foodborne pathogen detection. In this strategy, target amplification products are enzymatically digested to generate programmable single-stranded DNA activators, enabling PAM-independent Cas12a activation and flexible target recognition. Upon activation, Cas12a exhibits efficient trans-cleavage activity, which subsequently triggers terminal deoxynucleotidyl transferase (TdT)-mediated extension, forming an enzymatic cascade that amplifies signal output and generates a high-contrast signal-on readout on lateral flow assays. Integrating RPA and enzymatic digestion with PAM-free Cas12a-TdT signal amplification into two sequential one-pot modules simplifies the workflow, minimizes contamination risk, and maintains effective amplification performance. Under optimized conditions, PAEC-LFA achieved detection limits of 1.05 CFU/mL for Salmonella and Staphylococcus aureus, and 3.13 CFU/mL for Pseudomonas aeruginosa. Visual detection limits in spiked food samples reached 10 CFU/mL for all three pathogens. This work establishes a generalizable PAM-free enzymatic cascade framework for highly sensitive CRISPR/Cas12a lateral flow assays, advancing practical pathogen detection in food safety applications.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: